Video Series

Michael D. Shapiro, DO, and Erin D. Michos, MD, MHS, discuss the disproportionately high Lp(a) levels seen across different demographic groups, and the need for increased screening and treatment to mitigate the risk of cardiovascular disease.

Amy Nguyen Howell, MD, MBA, emphasizes ophthalmologists' crucial role in reducing diabetic macular edema (DME) health disparities.

Trajectory of patient outcomes for those diagnosed with bronchiectasis is explored by Dr Metersky.

A panel of medical experts discuss the shift from intervention to prevention in the management of dry eye disease, as well as perspectives on resource allocation.

Experts provide a perspective on disparities in accessibility and outcomes based on the current socioeconomic landscape in health care.

Medical experts discuss unmet needs surrounding treatment of multiple myeloma.

Experts discuss evolving strategies in ER+/HER2– metastatic breast cancer treatment, combining endocrine and targeted therapies, and leveraging specific mutations for optimal patient outcomes.

Key opinion leaders open a discussion surrounding CLL and SLL, and describing unique characteristics of each disease state.

A panel of experts explore desmoid tumor clinical characteristics, heterogeneity, and diagnostic complexities for optimal treatment strategies.

Medical professionals discuss strategies and best practices for recognizing and mitigating immunotherapy toxicities through multidisciplinary collaboration and use of monitoring technology.

The panel emphasizes the role of multidisciplinary tumor boards in optimizing oncology care in nonmelanoma skin cancers.

Therapeutic and financial considerations of EVT are explored by a medical expert.

An expert panel unpacks challenges in implementing bispecific therapies for operational excellence.

Dr Haumschild leads a discussion highlighting key care team members shaping the bispecific therapy decision-making processes.

A panel of medical experts break down the pathophysiology and current treatment landscape surrounding Ph+ ALL.

Amy Nguyen Howell, MD, MBA, highlights health equity issues and racial disparities in the prevalence and treatment of diabetic macular edema and emphasizes the influence of social determinants of health aspects on patient outcomes.

Novel therapies in MDS treatment are evaluated by a panel of experts led by Dr Haumschild.

Key opinion leaders discuss the process of adapting MDS treatment strategies for optimal impact of care.

Elizabeth Yeu, MD, discusses complications that may arise from inadequate treatment of Demodex blepharitis.

Elizabeth Spencer, MD, discusses various treatments for eosinophilic esophagitis (EoE) across age groups, highlighting the role of dietary modifications, proton pump inhibitors, swallowed corticosteroids, and monoclonal antibodies.

Michael D. Shapiro, DO, and Erin D. Michos, MD, MHS, explain the importance of the global Lp(a)HERITAGE study, emphasizing prevalence of elevated Lp(a) among different populations and the evolving approach to assessing Lp(a) levels.

Aaron Gerds, MD, MS, reviews myeloid disorder myelofibrosis and presents diverse symptoms, from blood count variations to spleen enlargement.

Jaime Murillo, MD, explores genetic inheritance patterns of Lp(a) from childhood to adulthood, highlighting stability, factors affecting measurement, and awareness challenges among those in the health care community.

Elizabeth Spencer, MD, discusses how EoE can affect children's activities and social interactions.

Mark Metersky, MD, FCCP, illustrates the pathology of bronchiectasis.

Key opinion leaders highlight the importance of identifying and treating dry eye disease to mitigate long-term economic burdens.